Market Research Reports and Industry Reports

Celon Pharma SA (CLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutical products, to treat various therapeutic diseases such as cancers, neurological diseases, diabetes and other metabolic disorders. Celon Pharma conducts its business activities through its research and development center and Storage and packaging plant. The company works in collaboration with academic and scientific institutions for the discovery of novel drugs. It also provides funds for other organizations for the development of new projects. Celon Pharma is headquartered in Lomianki, Poland.

Celon Pharma SA (CLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celon Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Celon Pharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Celon Pharma Enters into Agreement with Mabion 10
Lupin Enters into Development Agreement with Celon for Generic Advair Diskus 11
Licensing Agreements 12
Celon Pharma and Polfarmex Enter into Licensing Agreement with a Pharmaceutical Company 12
Glenmark Generics Enters into Licensing Agreement with Celon Pharma 13
Equity Offering 14
Celon Pharma Raises USD63 Million in IPO 14
Celon Pharma SA - Key Competitors 15
Celon Pharma SA - Key Employees 16
Celon Pharma SA - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
Jun 01, 2016: Celon Pharma focuses on the development of an inhalation technology in the treatment of asthma and COPD in a research project co-financed under the Smart Growth Operational Programme 2014-2020 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Celon Pharma SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celon Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celon Pharma SA, Deals By Therapy Area, 2011 to YTD 2017 8
Celon Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Celon Pharma Enters into Agreement with Mabion 10
Lupin Enters into Development Agreement with Celon for Generic Advair Diskus 11
Celon Pharma and Polfarmex Enter into Licensing Agreement with a Pharmaceutical Company 12
Glenmark Generics Enters into Licensing Agreement with Celon Pharma 13
Celon Pharma Raises USD63 Million in IPO 14
Celon Pharma SA, Key Competitors 15
Celon Pharma SA, Key Employees 16
Celon Pharma SA, Other Locations 17

Celon Pharma SA (CLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and

USD 250View Report

Acelon Chemicals & Fiber Corp (1466) - Financial and Strategic SWOT Analysis Review

Acelon Chemicals & Fiber Corp (Acelon Chemicals) is a chemicals manufacturer that produces and sells textile chemical filaments and yarns. The companys products include polyester yarn, nylon 6 yarn, nylon

USD 300View Report

Innate Pharma SA Strategic Analysis Review- Innate Pharma SA SWOT, Outlook, Operations and Financial Profile

Innate Pharma SA Company Profile provides strategic analysis of Innate Pharma SA Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200View Report

Erytech Pharma SA Strategic Analysis Review- Erytech Pharma SA SWOT, Outlook, Operations and Financial Profile

Erytech Pharma SA Company Profile provides strategic analysis of Erytech Pharma SA Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :19
Country :Poland
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube